4//SEC Filing
Berger Dietmar 4
Accession 0001209191-18-028449
CIK 0001604464other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:02 PM ET
Size
7.3 KB
Accession
0001209191-18-028449
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-05-07+85,000→ 85,000 totalExercise: $42.05Exp: 2025-05-06→ Common Stock (85,000 underlying) - Award
Common Stock
2018-05-07+50,000→ 50,000 total
Footnotes (2)
- [F1]25% of the shares subject to restricted stock units vest on May 7, 2019 and the remaining shares vest in equal annual installments over the following 3 years.
- [F2]25% of the shares subject to the option vest on May 7, 2019 and the remaining shares vest in equal monthly installments over the following 36 months.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001739515
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:02 PM ET
- Size
- 7.3 KB